Recently, we introduced a new electrochemical
imaging technique
called fluorescence-enabled electrochemical microscopy (FFEM). The
central idea of FEEM is that a closed bipolar electrode is utilized
to electrically couple a redox reaction of interest to a complementary
fluorogenic reaction converting an electrochemical signal into a fluorescent
signal. This simple strategy enables one to use fluorescence microscopy
to observe conventional electrochemical processes on very large electrochemical
arrays. The initial demonstration of FEEM focused on the use of a
specific fluorogenic indicator, resazurin, which is reduced to generate
highly fluorescent resorufin. The use of resazurin has enabled the
study of analyte oxidation reactions, such as the oxidation of dopamine
and H2O2. In this report, we extend the capability
of FEEM to the study of cathodic reactions using a new fluorogenic
indicator, dihydroresorufin. Dihydroresorufin is a nonfluorescent
molecule, which can be electrochemically oxidized to generate resorufin.
The use of dihydroresorufin has enabled us to study a series of reducible
analyte species including Fe(CN)63– and
Ru(NH3)63+. Here we demonstrate the
correlation between the simultaneously recorded fluorescence intensity
of resorufin and electrochemical oxidation current during potential
sweep experiments. FEEM is used to quantitatively detect the reduction
of ferricyanide down to a concentration of approximately 100 μM
on a 25 μm ultramicroelectrode. We also demonstrate that dihydroresorufin,
as a fluorogenic indicator, gives an improved temporal response and
significantly decreases diffusional broadening of the signal in FEEM
as compared to resazurin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.